Smith & Wesson (SWBI) Q4 Adj. EPS $0.36 Beats $0.23 Estimate; Sales Hit $178.4M
Alpha Stocks Insight Staff
Independent stock news and analysis covering NASDAQ and NYSE markets.
Adjusted EPS of $0.36 beat the $0.23 consensus by 56.5%, while $178.4M in sales topped the $155.3M estimate by nearly 15% , SWBI also raised its dividend.
Smith & Wesson Brands (NASDAQ: SWBI) posted adjusted EPS of $0.36 for its fiscal fourth quarter, beating the analyst consensus estimate of $0.23 by 56.5% and marking an 80% increase over the $0.20 adjusted EPS recorded in the same quarter a year ago. Revenue of $178.388M surpassed the $155.269M consensus estimate by approximately 14.9%, according to Benzinga. The company also announced a dividend increase to 13 cents per share, per Stock Titan.
Q4 Fiscal 2026 Results
- Adjusted EPS of $0.36 beat the $0.23 Wall Street estimate by 56.5%, up 80% year over year from $0.20.
- Revenue of $178.388M cleared the $155.269M consensus estimate, representing the top-line beat for the quarter.
- Dividend raised to 13 cents per share, signaling confidence in cash generation from management.
- Three consecutive quarters of EPS beats: Q4 2026 (+56.5%), Q3 2026 (+56.9%), Q2 2026 (+68.1%), showing a sustained pattern of outperformance against analyst estimates.
What Drove the Results
Adjusted EPS of $0.36 beat the $0.23 consensus by 56.5%, and revenue of $178.388M exceeded the $155.269M estimate by roughly $23M, indicating demand for SWBI's firearm products ran materially above what analysts had modeled. The year-over-year EPS gain of 80% reflects a significant improvement in profitability compared to the prior-year quarter's $0.20. The dividend raise to 13 cents per share, disclosed alongside the earnings release per Stock Titan, suggests management views the earnings improvement as durable enough to return additional capital to shareholders.
The quarterly beat extends a streak that now spans at least three consecutive periods. In the quarter ending March 2026, SWBI posted adjusted EPS of $0.08 against a $0.05 estimate, and in the quarter ending December 2025, it delivered $0.04 against a $0.02 estimate. Each quarter carried a surprise in the range of 56% to 68%, pointing to a consistent pattern of analysts underestimating the company's profitability. SWBI shares fell 1.08% during the regular Wednesday, June 17, 2026 session to close at $13.73 before the after-hours results were published.
Wall Street View
As of the June 1, 2026 consensus, seven of eight analysts covering SWBI carried Buy-equivalent ratings, with two at Strong Buy and five at Buy, against one Hold and no Sell recommendations. That breakdown was unchanged from the prior month's snapshot. One analyst, writing for Seeking Alpha, issued a downgrade to Hold ahead of the earnings release, citing valuation and industry conditions, though no specific new price target accompanied that action.
Investor Takeaway
SWBI's fiscal fourth quarter delivered a clean beat on both adjusted EPS ($0.36 vs. $0.23 estimate) and revenue ($178.388M vs. $155.269M estimate), while the dividend increase to 13 cents per share adds a tangible return-of-capital signal alongside the earnings outperformance. The 80% year-over-year EPS gain and the three-quarter streak of double-digit percentage beats indicate that near-term demand has repeatedly exceeded analyst models, though the lone Hold downgrade from Seeking Alpha flags that valuation and sector dynamics remain a consideration for investors assessing entry points.
Related Articles
Etsy (NYSE: ETSY) Surges on Q1 Earnings Beat Despite Modest 3.5% Revenue Growth
CarMax (NYSE: KMX) Posts $1.31 EPS in Q1, Beating $0.94 Consensus by 39%
Ulta Beauty (NASDAQ: ULTA) Beats Q1 2026 Estimates, Plans Times Square Flagship
Dollar General (DG) Q1 2026: EPS Beats at $2.00, Full-Year Profit Outlook Raised
Important Legal Disclaimer
This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.
Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.
